Benefits
DashboardNot registered yet? Get a free account.
Sign Up
PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES
Leave site?
You're about to leave our website and go to an external link. Are you sure?
Parmm Foundation For Advancement Of Research In Biomedical Sciences, is an unlisted private company incorporated on 18 December, 2024. It is classified as a not for profit company and is located in , Delhi. It's authorized share capital is INR 15.00 lac and the total paid-up capital is INR 12.00 lac.
The current status of Parmm Foundation For Advancement Of Research In Biomedical Sciences is - Active.
Read more
Buy Dashboard using Credits
Buy Dashboard using Credits
** All rupee values in INR crores.
-6.49%
-6.6%
190.59%
-7.96%
47.15%
3.46%
0.27
-0.13
7.03
7.53
-2.41
0.18
No Reports Available
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
Choose number of credits to buy
₹ 449 + GST
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
Locations
India
(1)
| State | Type | Address |
|---|
Locations on Map
Locations on Map
Filter (4)
Filter (4)
Select Tags
Choose Location
People
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Swati Singh | 08128855 | 2 years |
| Director | Misra Chandra Mahesh | 07826811 | 2 years |
Financial Highlights
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Margins
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets
Charges on assets
As per information available, the company has no registered charges.
Company Network
Companies connected through Directors
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| CYBERENUE SOFTWARE TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Delhi |
| YOGICSECRET HEALTHCARE PRIVATE LIMITED |
Active
|
1.4 Cr | 1 | Haryana |
| GOPADESK TECHNOLOGY (OPC) PRIVATE LIMITED |
Active
|
20,000.0 | 1 | Delhi |
| GUD MEDICARE SOLUTIONS PRIVATE LIMITED |
Active
|
1.5 L | 1 | Delhi |
| VAAG HEALTH FOUNDATION |
Active
|
0.0 | 1 | Uttar Pradesh |
| NEWWAVE HEALTHCARE SOLUTION PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| AGVA HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| MEDTAP HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| ONEZ TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| NEWWAVE HOSPITAL MEERUT PRIVATE LIMITED |
Active
|
1.0 L | 1 | Uttar Pradesh |
| D&D DOMINUS PRIVATE LIMITED |
Not available for efiling
|
1.0 L | 1 | Delhi |
| D&D TECHNOLOGIES LLP |
Active
|
1.0 L | 1 | Pradesh |
| KYAH HEALTHCARE LLP |
Active
|
10,000.0 | 1 | Delhi |
| SYNAPTICORE TECHNOLOGY PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| VYTALIX MEDICAL PRIVATE LIMITED |
Active
|
5.0 L | 1 | Delhi |
Tofler Score
Risk
Severe Risk
- No risks identified
Moderate Risk
- No risks identified
Low Risk
- No risks identified
About Tofler Score
Read more
Registered Details
CIN
U88900DL2024NPL440012PAN
-Incorporation
2024, 1.6 yearsCompany Email
admin@farbhealth.orgPaid up Capital
₹ 12.0 LAuthorised Capital
₹ 15.0 LAGM
N.A.Type
FAQ - PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES
What is the incorporation date of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES?
The incorporation date of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES is 18 December, 2024
What is the authorized share capital of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES?
The authorized share capital of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES is INR ₹ 15.0 L.
What is the paid-up capital of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES?
The paid-up capital of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES is INR ₹ 12.0 L.
What is the registered address of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES?
The registered address of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES is B7/94 Basement, Safdarjung Enclave extn., Nauroji Nagar, New Delhi, New Delhi, Delhi, India, 110029 - 110029
What is the CIN number of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES?
The CIN number of PARMM FOUNDATION FOR ADVANCEMENT OF RESEARCH IN BIOMEDICAL SCIENCES is U88900DL2024NPL440012.
